Trial to Assess Chelation Therapy (TACT)

Clinical Trial ID NCT00044213

PubWeight™ 19.58‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00044213

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA 2013 5.31
2 Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med 2013 3.08
3 Design of the Trial to Assess Chelation Therapy (TACT). Am Heart J 2012 2.09
4 The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes 2013 1.84
5 EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. Am Heart J 2014 1.61
6 New β-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother 2013 1.47
7 Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J Environ Public Health 2012 1.08
8 Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned. Medscape J Med 2008 0.90
9 Chelation: harnessing and enhancing heavy metal detoxification--a review. ScientificWorldJournal 2013 0.83
10 Iron and atherosclerosis: nailing down a novel target with magnetic resonance. J Cardiovasc Transl Res 2014 0.78
11 Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial. Circ Cardiovasc Qual Outcomes 2014 0.75
Next 100